The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the phase II TRUST trial of induction treatment with FOLFOXIRI + bevacizumab (BV) followed by chemo-radiotherapy (CRT) plus BV and surgery in locally advanced rectal carcinoma (LARC).
 
Gianluca Masi
Honoraria - Amgen; Merck Serono; Roche; Sirtex Medical
 
Sara Lonardi
No Relationships to Disclose
 
Aldo Sainato
No Relationships to Disclose
 
Piero Buccianti
No Relationships to Disclose
 
Giacomo Allegrini
No Relationships to Disclose
 
Angelo Martignetti
No Relationships to Disclose
 
Caterina Vivaldi
No Relationships to Disclose
 
Francesca Bergamo
No Relationships to Disclose
 
Sabrina Montrone
No Relationships to Disclose
 
Matteo Franceschi
No Relationships to Disclose
 
Lorenzo Marcucci
No Relationships to Disclose
 
Gianna Musettini
No Relationships to Disclose
 
Francesca Battaglin
No Relationships to Disclose
 
Gabriele Coraggio
No Relationships to Disclose
 
Riccardo Balestri
No Relationships to Disclose
 
Chiara Cremolini
No Relationships to Disclose
 
Isabella Paladina
No Relationships to Disclose
 
Lisa Salvatore
No Relationships to Disclose
 
Vittorina Zagonel
No Relationships to Disclose
 
Alfredo Falcone
Honoraria - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Speakers' Bureau - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Research Funding - Amgen; Bayer; Lilly; Roche; Sanofi